Enoxaparin
Also known as: Lovenox.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Package | Class |
|---|---|---|---|---|
| 30 MG/0.3 ML | Syringe | $9.62 / mL† | — | Generic |
| 40 MG/0.4 ML | Syringe | $8.06 / mL† | — | Generic |
| 60 MG/0.6 ML | Syringe | $7.84 / mL† | — | Generic |
| 80 MG/0.8 ML | Syringe | $7.13 / mL† | — | Generic |
| 100 MG/ML | Syringe | $7.37 / mL† | — | Generic |
| 120 MG/0.8 ML | Syringe | $11.81 / mL† | — | Generic |
| 150 MG/ML | Syringe | $10.63 / mL† | — | Generic |
| 300 MG/3 ML | Vial | $9.88 / mL† | — | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. † Package size not curated yet — priced per single unit/mL, not per full pen, inhaler, or vial.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $45,755,887 gross for Enoxaparin across 316,817 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$79,504,048 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS